Amicus Therapeutics Inc

XNAS: FOLD

Expensive Performer

Download real time

9.00 -0.08 (-0.88%)

28.85% Fall from 52W High

2.9M XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

2,765.2

Market Cap

High in industry

0.3

Beta 1Year

Very Low volatility

Amicus Therapeutics Inc - FOLD - stock price prediction, stock price target, analyst ratings from 12 analysts

Amicus Therapeutics Inc has a share price target of US$ 17, revenue growth forecast of 19.5%, and profit growth estimate of 115.1% for FY25, based on top 12 analyst calls.

Forecaster Screeners